How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic

British Journal of Dermatology

Volumn 170, Issue 4, 2014, Pages 766-771

  Kassim, J M ^a   Shipman, A R ^b   Szczecinska, W ^c   Siah, T W ^d   Lam, M ^e   Chalmers, J ^f   Macbeth, A E ^a,g  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b WARWICK HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e QUEEN S MEDICAL CENTRE   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; DITHRANOL; RETINOIC ACID; TACROLIMUS; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE; GLUCOCORTICOID;

ALOPECIA AREATA; ARTICLE; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE DURATION; DRUG EFFECT; DRUG SAFETY; FOLLOW UP; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IRRITANT DERMATITIS; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF ESTEEM; SKIN ATROPHY; SYSTEMATIC REVIEW; TOPICAL TREATMENT; ULTRAVIOLET RADIATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HAIR; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ALOPECIA AREATA; CONTROLLED CLINICAL TRIALS AS TOPIC; GLUCOCORTICOIDS; HAIR; HUMANS; INJECTIONS, INTRALESIONAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 84929942133     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12863     Document Type: Article

References (21)

1. Safavi KH, Muller SA, Suman VJ, et al,. Incidence of alopecia areata in Olmstead County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-33.
2. McDonagh AJG, Messenger AG,. The pathogenesis of alopecia areata. Dermatol Clin 1996; 14: 661-70.
3. Ikeda T,. A new classification of alopecia areata. Dermatologica 1965; 131: 421-45.
4. Walker SA, Rothman S,. Alopecia areata: a statistical study and consideration of endocrine influences. J Invest Dermatol 1950; 14: 403-13.
5. Gip L, Lodin A, Molin L,. Alopecia areata. A follow-up investigation of outpatient material. Acta Derm Venereol 1969; 49: 180-8.
6. Shapiro J, Price VH,. Hair regrowth: therapeutic agents. Dermatol Clin 1998; 16: 341-56.
7. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J,. Interventions for alopecia areata. Cochrane Database Syst Rev 2008; (2008): CD004413.
8. Messenger AG, McKillop J, Farrant P, et al,. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166: 916-26.
9. Porter D, Burton JL,. A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata. Br J Dermatol 1971; 85: 272-3.
10. Abell E, Munro DD,. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 1973; 88: 55-9.
11. Kubeyinje EP,. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr Med J 1994; 71: 674-5.
12. Frentz G,. Topical treatment of extended alopecia. Intralesional steroid-Kromayer lamp. Dermatologica 1977; 155: 147-54.
13. Narahari SR,. Comparative efficacy of topical anthralin and intralesional triamcinolone in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol 1996; 62: 348-50.
14. Kubeyinje EP, C'Mathur M,. Topical tretinoin as an adjunctive therapy with intralesional triamcinolone acetonide for alopecia areata. Clinical experience in northern Saudi Arabia. Int J Dermatol 1997; 36: 320.
15. Kuldeep CM, Singhal H, Khare AK, et al,. Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Int J Trichology 2011; 3: 20-4.
16. Wahab MA,. Results of intralesional triamcinolone in the treatment of alopecia areata. J Bangladesh Coll Phys Surg 2006; 24: 110-13.
17. Ganjoo S, Thappa DM,. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol 2013; 79: 408-17.
18. Chang KH, Rojhirunsakool S, Goldberg LJ,. Treatment of severe alopecia areata with intralesional steroid injections. J Drugs Dermatol 2009; 8: 909-12.
19. Olsen EA, Hordinsky MK, Price VH, et al,. Alopecia areata investigational assessment guidelines-part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-7.
20. Fabbrocini G, Panariello L, De Vita V, et al,. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol 2013; 27: e276-e81.
21. Centre for Evidence Based Medicine. OCEBM levels of evidence system. Available at: http://www.cebm.net/index.aspx?o=5513 (last accessed 7 January 2014).